Dual Effects of Cellular Immunotherapy in Inhibition of Virus Replication and Prolongation of Survival in HCV-Positive Hepatocellular Carcinoma Patients
Immune cells play an important role in the development and progression of hepatitis C virus (HCV) and hepatocellular carcinoma (HCC). We conducted a retrospective study to evaluate the influence of adoptive cellular immunotherapy (CIT) on viral load and progression-free survival (PFS) for HCC patien...
Saved in:
| Main Authors: | Lei Qian, Nanya Wang, Huimin Tian, Haofan Jin, Hengjun Zhao, Chao Niu, Hua He, Tingwen Ge, Wei Han, Jifan Hu, Dan Li, Fujun Han, Jianting Xu, Xiao Ding, Jingtao Chen, Wei Li, Jiuwei Cui |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2016-01-01
|
| Series: | Journal of Immunology Research |
| Online Access: | http://dx.doi.org/10.1155/2016/6837241 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
TCR-based cellular immunotherapy for hepatocellular carcinoma: advances, challenges, and prospects
by: Wanting Zeng, et al.
Published: (2025-07-01) -
Rituximab-Based Treatment, HCV Replication, and Hepatic Flares
by: Evangelista Sagnelli, et al.
Published: (2012-01-01) -
The Place of Immunotherapy in the Management of HCV-Induced Vasculitis: An Update
by: Laurent Chiche, et al.
Published: (2012-01-01) -
Evidence that the second human pegivirus (HPgV-2) is primarily a lymphotropic virus and can replicate independent of HCV replication
by: Zhengwei Wan, et al.
Published: (2020-01-01) -
Schistosoma mansoni soluble egg antigens enhance HCV replication in mammalian cells
by: Mahmoud Mohamed Bahgat, et al.
Published: (2010-02-01)